Even in comparison to other types of cancer, brain cancer is particularly deadly. People with glioblastoma multiforme, one of the most common forms of brain cancer, have a median survival of less than 15 months after diagnosis. The US Food and Drug Administration (FDA) has so far approved only five drugs for treating brain cancer. Given this limited range, researchers could search for potential treatments among the wider pool of all FDA-approved drugs; however, any found to be effective would probably work in just a slim percentage of people with brain cancer.
Commun Biol. 2019 Feb 25;2:78. doi: 10.1038/s42003-019-0305-x. eCollection 2019.
Ann Surg Oncol. 2019 Jan;26(1):139-147. doi: 10.1245/s10434-018-7008-2. Epub 2018 Nov 9.
Human Molecular Genetics, Volume 27, Issue R2, 01 August 2018, Pages R99–R107
Nature Reviews Cancervolume 18, pages407–418 (2018)
Science. 2018 Feb 23;359(6378):920-926. doi: 10.1126/science.aao2774.
Cell. 2018 Jan 11;172(1-2):373-386.
Subscribe to our newsletter
Stay up-to-date on the latest advancements in 3D cell culture technology